Literature DB >> 18815240

Media calcification and intima calcification are distinct entities in chronic kidney disease.

Kerstin Amann1.   

Abstract

Calcification of the vascular tree is common in physiologic and pathologic conditions, i.e., aging, diabetes, dyslipidemia, genetic diseases, and diseases with disturbances of calcium metabolism. In chronic kidney disease, vascular calcification is even more common, develops early, and contributes to the markedly increased cardiovascular risk in this particular population. Pathomorphologically, atherosclerosis (i.e., plaque-forming degenerative changes of the aorta and of large elastic arteries) and arteriosclerosis (i.e., concentric media thickening of muscular arteries) can be distinguished. Increasing knowledge about calcification together with improved imaging techniques provided evidence that also vascular calcification has to be divided into two distinct entities according to the specific sites of calcification within the vascular wall: Patchy calcification of the intima in the vicinity of lipid or cholesterol deposits as present in plaque calcification and calcification of the media in the absence of such lipid or cholesterol deposits, known as Mönckeberg-type atherosclerosis. The two types of calcification may vary according to the type of vessel (large elastic versus smaller muscular type artery) and proximal versus distal sites of the arterial tree. Furthermore, clinical studies showed that it is not purely academic to distinguish between intimal and medial calcification but rather relevant for the clinical presentation, treatment, and prognosis because each type leads to different clinical consequences. In vivo studies in animal models provided evidence in favor of common pathomechanisms between vascular calcification and atherosclerosis; however, there is other, strong experimental and clinical evidence that pleads for the continued distinction between intimal and medial calcification.

Entities:  

Mesh:

Year:  2008        PMID: 18815240     DOI: 10.2215/CJN.02120508

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  111 in total

1.  Calcification of the external carotid arteries and their branches.

Authors:  D S Macdonald; L Zhang; Y Gu
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

2.  Reversible vascular calcifications associated with hypervitaminosis D.

Authors:  Massimo Cirillo; Giancarlo Bilancio; Chiara Cirillo
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

Review 3.  Monckeberg's Medial Sclerosis as a Cause for Headache and Facial Pain.

Authors:  Davis C Thomas; Prisly Thomas; Anilkumar Sivan; Priyanka Unnam; Ahana Ajayakumar; Sanjana Santhosh Kumar; Priyanka Kodaganallur Pitchumani; Mahnaz Fatahzadeh; Nida-E-Haque Mahmud
Journal:  Curr Pain Headache Rep       Date:  2021-06-04

4.  SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.

Authors:  Jakob Voelkl; Trang Td Luong; Rashad Tuffaha; Katharina Musculus; Tilman Auer; Xiaoming Lian; Christoph Daniel; Daniel Zickler; Beate Boehme; Michael Sacherer; Bernhard Metzler; Dietmar Kuhl; Maik Gollasch; Kerstin Amann; Dominik N Müller; Burkert Pieske; Florian Lang; Ioana Alesutan
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

5.  Chronic kidney disease: Medial or intimal calcification in CKD-does it matter?

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2011-05       Impact factor: 28.314

6.  Chronic kidney disease: Arterial stiffness and renal function--a complex relationship.

Authors:  Paolo Salvi; Gianfranco Parati
Journal:  Nat Rev Nephrol       Date:  2014-12-09       Impact factor: 28.314

7.  Vascular calcification in predialysis CKD: common and deadly.

Authors:  Wei Chen; Michal L Melamed
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-13       Impact factor: 8.237

8.  Coronary calcification in patients with chronic kidney disease and coronary artery disease.

Authors:  Satoko Nakamura; Hatsue Ishibashi-Ueda; Sinichiro Niizuma; Fumiki Yoshihara; Takeshi Horio; Yuhei Kawano
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

Review 9.  Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Authors:  Patrick S Parfrey; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; Sharon M Moe; David C Wheeler; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 8.237

Review 10.  The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences.

Authors:  Venkata Narla; Michael J Blaha; Roger S Blumenthal; Erin D Michos
Journal:  Vasc Health Risk Manag       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.